PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the Body in Healthy Adults
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 26
- Registration Number
- NCT06003777
- Locations
- 🇺🇸
Pfizer Clinical Research Unit - New Haven, New Haven, Connecticut, United States
A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants.
- Conditions
- Healthy
- Interventions
- Drug: SinsunatovirOther: Bitrex
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT06003829
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 472
- Registration Number
- NCT06003114
- Locations
- 🇨🇦
Alberta Health Services, Edmonton, Alberta, Canada
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
- First Posted Date
- 2023-08-18
- Last Posted Date
- 2024-03-28
- Lead Sponsor
- Pfizer
- Registration Number
- NCT05997485
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 340
- Registration Number
- NCT05995964
- Locations
- 🇺🇸
Allervie Clinical Research, Birmingham, Alabama, United States
🇺🇸Medical Dermatology Specialists, Phoenix, Arizona, United States
🇺🇸Banner - University Medicine Dermatology Clinic, Tucson, Arizona, United States
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 25
- Registration Number
- NCT05994963
- Locations
- 🇧🇪
Pfizer Clinical Research Unit - Brussels, Brussels, Bruxelles-capitale, Région DE, Belgium
A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1414
- Registration Number
- NCT05989048
- Locations
- 🇨🇳
Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳The Second People's hospital of Hefei, Hefei, Anhui, China
🇨🇳The First Medical Center of Chinese PLA General Hospital, Beijing, Beijing, China
A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT05987072
- Locations
- 🇨🇳
Huashan Hospital, Shanghai, Shanghai, China
🇨🇳Huashan Hospital, Fudan University, Shanghai, Shanghai, China
🇨🇳Huashan Hospital Fudan University, Shanghai, Shanghai, China
Voxelotor CYP and Transporter Cocktail Interaction Study
- Conditions
- Sickle Cell Disease
- Interventions
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 44
- Registration Number
- NCT05981365
- Locations
- 🇺🇸
ICON Early Phase Services, LLC, San Antonio, Texas, United States
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
- Conditions
- Prostatic Neoplasms, Castration-Resistant
- Interventions
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 2731
- Registration Number
- NCT05968599
- Locations
- 🇺🇸
Pfizer Inc, New York, New York, United States